According to Vaxcyte
's latest financial reports the company has $1.74 Billion USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | $1.74 B | 61.74% |
2023-12-31 | $1.08 B | 15.98% |
2022-12-31 | $0.93 B | 278.65% |
2021-12-31 | $0.24 B | -36.31% |
2020-12-31 | $0.38 B | 554.84% |
2019-12-31 | $58.97 M | -10.76% |
2018-12-31 | $66.09 M |